ACROBiosystems offers a comprehensive collection of recombinant Fc receptor proteins including FcRn FcγRs, FcεRs to expedite antibody drug development and research programs.
The efficacy of therapeutic antibodies depends on its interaction with FcRn and FcγRs. Therefore, candidates must be tested against a panel of receptors during antibody engineering.
Main features:
Expressed by HEK293 Cells: post-translational modification and proper protein folding